Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Nov 12:13:70.
doi: 10.1186/1471-2415-13-70.

MAPK activation in mature cataract associated with Noonan syndrome

Affiliations
Case Reports

MAPK activation in mature cataract associated with Noonan syndrome

Noriyasu Hashida et al. BMC Ophthalmol. .

Abstract

Background: Noonan syndrome is an autosomal, dominantly inherited disease; it is physically characterized by short stature, short neck, webbed neck, abnormal auricles, high arched palate, and cardiovascular malformation. Its pathological condition is thought to be due to a gain-of-function mutation in the Ras-mitogen-activated protein kinase (MAPK) signal transduction pathway. Eyelid abnormalities such as ocular hypertelorism and blepharoptosis are the most commonly observed eye complications.

Case presentation: We report a case of Noonan syndrome associated with mature cataract that required operation. A 42-year-old man was diagnosed with Noonan syndrome at the age of 1 year. He underwent an eye examination after complaining of decreased visual acuity in the right eye and was diagnosed with mature cataract, which was treated by cataract surgery. There were no intraoperative complications, and the postoperative course was uneventful. Protein analysis of lens capsule and epithelium at capsulorhexis showed MAPK cascade proteins such as ERK and p38MAPK were upregulated. An abnormality in the PTPN11 gene was also observed; a potential mechanism of cataract onset may be that opacity of the lens rapidly progressed due to abnormal activation of the Ras-MAPK signal transduction pathway.

Conclusion: This case highlights the possible association of cataract formation with MAPK cascade protein upregulation in Noonan syndrome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Characteristic facial appearance. Patient presents with typical appearance such as exophthalmos and abnormal auricles.
Figure 2
Figure 2
Slit lamp examination on initial before and after the surgery. Initial slit lamp examination revealed (A) mature cataract in the right eye (A) and mild cataract in the left eye (B). (A) Mature cataract was observed in the right eye. Slit lamp examination after the cataract surgery in the right eye (C) and the left eye (D), showing no complication.
Figure 3
Figure 3
Fundus photograph before and after the surgery. (A) Fundus photograph of the right eye, but fundus could not be seen due to mature cataract. (B) Fundus photograph of the left eye, showing normal appearance. Recent fundus photograph after the cataract surgery in the right eye (C) and the left eye (D), showing normal appearances.
Figure 4
Figure 4
Western blot analysis of p38α MAP Kinase. Western blot of p38α MAP Kinase in lens capsule and epithelium at capsulorhexis from the patient with Noonan syndrome and senile cataract (control). Blot probed with the anti- p38α MAP Kinase antibody was detected in lens lysates from the patient with Noonan syndrome, but not from the patient with senile cataract (control).
Figure 5
Figure 5
Western blot analysis of phosphorylated ERK. Phosphorylated extracellular signal-regulated kinase (p-ERK1/2) expression in Western blot. (A) A representative blot. p-ERK expression in lens lysates from the patient with Noonan syndrome and senile cataract (control). Western blot analysis revealed that p-ERK expression increased in lens lysates from the patient with Noonan syndrome. (B) Semi-quantitative analysis of the band intensity showed an increase in relative p-ERK expression (values normalized to total ERK expression) in lens lysates from the patient with Noonan syndrome compared with that from control (n = 6, *P < 0.001).

References

    1. Noonan JA, Ehmeke DA. Associated non-cardiac malformatons in children with congenital heart disease. J Paediatr. 1963;63:468–470.
    1. Allanson JE. Noonan syndrome. Am J Med Genet C: Semin Med Genet. 2007;145C:274–279. doi: 10.1002/ajmg.c.30138. - DOI - PubMed
    1. Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb BD. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001;29:465–468. doi: 10.1038/ng772. - DOI - PubMed
    1. Digilio MC, Conti E, Sarkozy A, Mingarelli R, Dottorini T, Marino B, Pizzuti A, Dallapiccola B. Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. Am J Hum Genet. 2002;71:389–394. doi: 10.1086/341528. - DOI - PMC - PubMed
    1. Tartaglia M, Gelb BD, Zenker M. Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab. 2011;25:161–179. doi: 10.1016/j.beem.2010.09.002. - DOI - PMC - PubMed

Publication types

Substances